A study soon to published found that palliative care for patients with ovarian cancer was often provided later than recommended in national guidelines.
A recent study evaluated the impact of a geriatric oncology clinic on cancer treatment plans and supportive care in older adults with genitourinary cancers.
The National Comprehensive Cancer Network updated their induction and consolidation treatment recommendations for low-risk and high-risk acute myeloid leukemia.
The FDA has approved a hormone-based chemotherapy in combination with prednisone for metastatic high-risk castration-sensitive prostate cancer.
A cost-effectiveness analysis presented at the 2018 Genitourinary Cancers Symposium examined the use of a hydrogel rectal spacer in patients with prostate cancer undergoing intensity-modulated radiation therapy.
Human epidermal growth factor receptor 2 may be a potential marker of poor prognosis in patients with unclassified ovarian cancer, according to a recent meta-analysis.
The American Society of Clinical Oncology as endorsed other professional societies’ molecular guidelines on selecting patients with lung cancer for treatment with targeted tyrosine kinase inhibitors.
About 15% of Medicare recipients and 23% of those with commercial insurance undergo breast biopsy by 10-year follow-up, and biopsy is associated significantly with age, initial treatment type and subsequent chemotherapy.
Researchers compared the overall survival, cancer-specific survival, and associated costs of trimodal therapy versus radical cystectomy for patients with localized muscle-invasive bladder cancer.